The aim of this review is to look critically at the widely accepted notion that visceral fat accumulation is the main determinant of obesity related diseases. Most of the epidemiological evidence is based on anthropometric indicators of fatness and fat distribution and their implications for visceral fat accumulation may not be unequivocal. In most cross-sectional studies in which visceral fat is associated with the level of risk factors or presence of disease, no adjustment is made for potential confounders. There are potential confounders at different levels of the causal chains linking visceral fat to health. Firstly, there are aspects of body composition or fat depots associated with visceral fat accumulation such as total body fat or total subcutaneous fat. Total and subcutaneous fat are, by themselves, potentially strong determinants for metabolic disturbances and disease. Secondly, there are behavioural factors (for example smoking, alcohol consumption, physical activity, dietary habits) which have been found to be associated with both the amount of visceral fat and health outcomes. Thirdly, there are hormonal mechanisms (adrenal and gonadal steroids as well as growth hormone) which may affect both the accumulation of visceral fat as well as the development of diseases. Finally, even if associations between visceral fat and risk factors or presence of diseases would be ®rmly established, the causality of the observed associations may not always be easy to interpret. Prospective studies are needed with appropriate control of potential confounding variables. It is concluded that, based on the current evidence, it is dif®cult to quantify the independent contribution of visceral fat to the development of a variety of chronic diseases.
Introduction
It is fascinating to see how rapidly the notion that the amount of abdominal visceral fat is the major fat depot impacting on health and disease has gained acceptance in the obesity research ®eld. In such circumstances, maintaining a certain degree of scepticism is likely to be the best attitude to adopt while insisting that the proponents of the concept provide us with unequivocal and orbits data. This paper identi®es some of the reasons that may confound the reported relationships between visceral fat and risk factors or disease outcomes, and documents the reasons why we believe it is appropriate to maintain a healthy dose of scepticism.
When Vague 1 ®rst introduced the concept of the importance of fat distribution as a characteristic of obese people who had developed diabetes mellitus or cardiovascular disease, he speci®cally wrote about upper body (android) obesity and lower body (gynoid) obesity. He developed the Index of Masculine Differentiation which was based on the skinfolds in the nape of the neck and sacrum and the Brachiofemoral adipo-muscular ratio which was a ratio of a ratio and included skinfolds relative to circumferences of the arm divided by skinfolds relative to circumferences of the upper thigh. It was a complex ratio of several anthropometric measurements, one that is not easily amenable to interpretation. Later work concentrated on skinfold patterning in relation to gender, age, maturation, and disease 2 or on regional fat cell sizè hypertrophic' and`hyperplastic' obesity. 3 Accumulation of intra-abdominal or visceral fat was not mentioned in any of the early publications.
The concepts established by Vague 1 were subsequently translated into the waist-to-hip circumference ratios and waist-to-thigh circumference ratios.
4±6 Soon after the development of computer assisted tomography, investigators devised methods to quantify the surface area or volume of fat in the abdominal cavity. 7±9 Ashwell et al. 10 was the ®rst to suggest that the waist-to-hip circumference ratio was more closely associated with intra-abdominal fat than with subcutaneous fat. 10 Subsequently, Sparrow et al. 11 demonstrated that diabetics had more intra-abdominal fat compared to non-diabetics. Investigators from the United States of America, 12 Sweden 13 and Canada 14 have since developed hypotheses that were consistent with the speci®c role of visceral fat in the associations between obesity and diabetes mellitus and cardiovas-cular risk factors. Gradually it has become accepted that any association of the waist-to-hip circumference ratio to disease is indicative of the`bad' fat (intraabdominal or visceral fat) and this ratio has been progressively seen as a valid surrogate for visceral fat despite clear evidence to the contrary. Others have even speculated that subcutaneous fat may be harmless or even bene®cial for health. 15 In the remainder of this short review, we examine whether the evidence supports these views and if such an interpretation of the data is correct.
Potential confounders in the relation between visceral fat and health
Although there are widely available methods now to directly measure the intra-abdominal fat volume directly such as computed tomography and magnetic resonance imaging, 16 relatively few studies have adequately controlled for potential confounders in the relation between visceral fat and health. Moreover, most studies were performed in relatively small selected groups of obese subjects or focused primarily on cross-sectional association with risk factor levels or were relatively small case-control studies comparing subjects with, for instance, diabetes mellitus to healthy controls. All the population based prospective studies linking fat distribution to health have relied on anthropometric measurements. Table 1 lists some of the confounders that may explain, at least partly, the observed association between visceral fat and risk factors or disease. Not mentioned in the table is age which is both associated with visceral fat and increased health risks. Age is one of the variables for which most investigators properly make adjustments.
Body composition and other fat depots
It has been frequently shown that increased levels of visceral fat are associated with increased total body fat and increased amounts of subcutaneous fat. Adjustment for body mass index, although relatively strongly correlated with total body fat, is insuf®cient to properly control for the effects of total body fat on the relation between visceral fat and risk factors. Unfortunately, most studies have not even controlled for body mass index let alone for total fat mass. Table 2 shows an example of the effects of adjustment for age and total body fat on the associations between visceral fat area and lipid levels in 45 obese premenopausal women and 46 obese men. 17 Correlations between age and visceral fat area in this study were 0.33 in women (P`0.05) and 0.59 in men (P`0.001). Correlations between visceral fat area and body fat were 0.17 in women and 0.61 (P`0.001) in men. These correlations were arti®cially low in this particular study because the obese subjects were selected to cover a wide range of body fat distribution but not a wide range of obesity. Although the associations in women were not markedly affected by the adjustment for total body fat, it is clear that in men the associations between visceral fat and serum lipids were reduced to nonsigni®cant levels. Table 3 shows that visceral fat area is somewhat more strongly associated with risk factors than total body fat in obese women, but that total body fat shows substantial correlations with these risk factors. Adjustment for total body fat is likely to lead to weakening of these correlations. Although abdominal subcutaneous fat areas also tend to be less strongly associated with risk factors compared to visceral or total body fat the, rarely measured, total subcutaneous fat mass is the major component of total body fat, particularly in women.
Although we do not intend to review the literature exhaustively, we think it is fair to say that it remains to be established what the contribution of visceral fat to risk factors is over and above that of total body fat. In one elegant study the effects of total, subcutaneous fat and visceral fat on the development of insulin resistance in a prospective study were separated and it was shown that changes in visceral fat were independent correlates of changes in insulin and glucose concentrations. 18 Although these associations were impressive given the small sample size of the study, the results need to be replicated in more prospective studies. In another recent study the importance of visceral fat in NIDDM could not be con®rmed 19 while, in a report from the same group, 20 subcutaneous truncal fat was a better correlate of obesityrelated insulin resistance than intra-abdominal fat. It is not unlikely that some of the associations between visceral fat and risk factors are truly signi®cant, but also that many of these associations are, at least partly, attributable to confounding effects of subcutaneous or total body fat.
Life style factors
In only a handful of studies the associations between smoking, physical activity or inactivity and alcohol use on the one hand and visceral fat accumulation on the other were studied. In a ®rst series of studies it was observed that smokers tended to be leaner but had higher waist/hip ratios, that inactive people have higher waist/hip ratios compared to active people and that alcohol use was positively associated with increased waist/hip ratio. 21 Although these associations with ratios should be viewed with caution they have generally been interpreted as indicating that smoking, alcohol use and being inactive leads to preferential accumulation of intraabdominal fat. More recent studies have revealed that this interpretation was probably correct. Abdominal visceral fat level can be reduced by regular physical activity. For instance, when exercise was used to cause a chronic state of negative energy balance, the decrease in visceral fat area or volume was, or tended to be, more pronounced than the subcutaneous fat loss. 22, 23 Smoking may induce accumulation of visceral fat. In a small cross-sectional study in Swedish men it was observed that those who smoked had more visceral fat, but not more subcutaneous fat, compared to nonsmoking men. 24 Alcohol consumption has been shown to be correlated more strongly to visceral fat than to subcutaneous fat in Italian women. 25 Although we will not attempt to explain these associations, potential mechanisms generally include mediating factors such as corticosteroid and sex hormone metabolism (see next section). Smoking and inactivity are particularly strong determinants of diseases associated with obesity such as cardiovascular disease and non-insulin dependent diabetes mellitus and may therefore be potential confounders in the relation between visceral fat and disease. With regard to dietary factors in relation to fat distribution and risk factors there has been, to our knowledge, no research on dietary composition (for example fat content of the diet) and direct estimates of visceral fat. Potentially, however, high fat diets may promote accumulation of visceral fat and unfavourably increase the risk of cardiovascular disease and diabetes mellitus.
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Hormonal factors
One of the earliest indications that visceral fat accumulation was associated with glucocorticoid metabolism came from clinical studies on patients with Cushing's syndrome. 28, 29 Since then it has been proposed that also physiological variation in cortisol levels may also be associated with increased visceral fat. In one study in healthy volunteers a positive association was seen between 24 h cortisol secretion and waist/hip ratio as well as the abdominal sagittal diameter. 30 The involvement of the hypothalamicpituitary-adrenal axis in the accumulation of visceral fat was con®rmed in a study in Italian obese women who were strati®ed into two age-matched groups with fat distribution characterised as`visceral' and`subcutaneous. 31 It was demonstrated that, following a physiological stress challenge (combined corticotrophin-releasing factor and arginine-vasopressin stimuli), women with visceral obesity had higher cortisol levels compared to women with subcutaneous obesity. 31 Several investigators have proposed that increased cortisol production may be related to both visceral fat accumulation and to increased levels of cardiovascular risk factors as well as insulin resistance. 32, 33 These observations also provide a link between behavioural factors such as smoking and mental stress to visceral fat accumulation and health risks. 32 In a recent review it was noted that insulin resistance is likely to be exacerbated by excess glucocorticoids 31 and that VLDL and apo B production can be stimulated by glucocorticoids. It has been repeatedly shown that increased abdominal fatness (usually measured by waist/hip ratio) is associated with an increased degree of androgenicity in women. 35, 36 No direct measures of visceral fat had been linked to increased concentrations of free testosterone concentrations in healthy women. In long-term treatment with testosterone of female-to-male transsexuals, however, an increased visceral fat accumulation and reduced subcutaneous fat accumulation have been noted 37 making it likely that testosterone levels in women are causally related to visceral fat. In women, testosterone administration also leads to increased insulin resistance 38 and hepatic lipase activity and LPL activity are both sensitive to testosterone and may therefore lead to decreased HDLcholesterol. 34 These associations remain, however, somewhat ambiguous since total body fat and other poten-tial confounders are rarely taken into consideration.
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In men, these associations are markedly different. Increased visceral fat areas have been associated with low testosterone levels 39 and administration of testosterone in men with low-normal testosterone levels leads to decreased visceral fat areas and to improved insulin sensitivity. 40 The role of oestrogen's is less clear although the lack of oestrogen's has been implicated in the postulated increased accumulation of visceral fat as well as in the unfavourable changes in cardiovascular risk factors observed after menopause.
Finally, a negative correlation was observed between the level of insulin-like growth factor-1 (IGF-1) and visceral fat area in overweight Danish subjects. 41 In addition, it was shown that 26 weeks of replacement therapy with recombinant human growth hormone in adults with growth hormone de®ciency led to a larger increase in visceral adipose tissue volume (30%) than in subcutaneous tissue volume (13%). 42 Similar results have been obtained by others. 43 Growth hormone de®ciency is associated with increased cardiovascular morbidity and growth hormone treatment favourably changes lipoprotein concentrations. 44 These results suggest that also low growth hormone levels are associated with increased visceral fat accumulation and increase cardiovascular risk. All these observations make it possible that factors which are affecting adrenal and sex steroid concentrations and growth hormone levels may be in¯uen-cing visceral fat accumulation and risk factor levels at the same time. This makes these hormonal concentrations strong candidates as potential confounders in the relation between visceral fat accumulation and disease.
Other factors
A high waist/hip ratio has been associated with a tendency to a higher proportion of type IIb muscle ®bers. 45, 46 These muscle ®bers may, by themselves, be associated with decreased glucose transport and reduced insulin sensitivity. 45, 46 However, it is more likely that skeletal muscle metabolism is the best correlate of insulin action rather than ®ber type distribution. 47 The role of skeletal muscle in the relationship between visceral fat and insulin resistance remains to be fully elucidated. In one study 48 it was observed that visceral fat area was associated with skeletal muscle insulin resistance but this was not due to glucose-free fatty acid substrate competition in muscle. Instead, women with visceral obesity were found to have reduced postabsorbtive free fatty acid utilisation by muscle. 48 In addition, it has been proposed that diabetics have higher waist/hip ratios compared to non-diabetics partly because they have larger waist circumferences (and thus may have more visceral fat) but also because they have smaller hip circumferences than can be expected on the basis of their age and body mass index. 49 Peripheral wasting of muscle may be cause or consequence of NIDDM independent of visceral fat accumulation. 50 Interpretation of ratios of circumferences should be made with caution.
Conclusion
There is substantial circumstantial evidence to link visceral fat to increased risk for diabetes and coronary heart disease. Among the reasons why visceral fat may be a particular strong determinant of risk are the relatively high responsiveness to lipolytic stimuli (for example noradrenaline) and low responsiveness to anti-lipolytic stimuli (for example insulin) of omental fat cells compared to subcutaneous fat cells. Another important reason is the venous drainage of visceral fat to the portal vein as opposed to the drainage of subcutaneous fat to the peripheral circulation. 51 It is, however, important to realise that there is no direct evidence linking visceral fat to the proposed metabolic sequel other than cross-sectional associations. There are many potential confounders in the association between visceral fat and disease ( Figure 1 ) and further research is needed to quantify the independent contribution of visceral fat to disease.
Most studies that have reported a relationship between visceral fat and a risk factor or morbidity have not properly controlled for the concomitant effect of total body fat. In those studies where such adjustments were made have often observed that visceral fat had only a slightly stronger association with risk factors or morbidity than total body fat. It is therefore absolutely essential to eliminate the concomitant and potentially confounding effect of total fat mass in any research where the aim is to assess the consequences of visceral fat accumulation. We have reached the stage where no study should be published without adequate controls over total body fat and the important other confounders if we are to make progress in this area, particularly in light of recent studies suggesting that subcutaneous fat may, after all, be the most important correlate of insulin resistance. In epidemiological research we therefore need better estimates of total body fat and visceral fat than the crude anthropometric measures such as BIM and waist/hip circumference ratios as currently used in most studies. Finally, one must also always keep in mind that the generally observed cross-sectional associations between visceral fat and risk factors may represent another temporal relationship than is assumed. A good example of this is a ®ve-year follow up study in which greater insulin resistance and reduced insulin secretion preceded the increase in visceral fat. 52 We think that the question in the subtitle of this short review cannot be answered with certainty. There are many plausible mechanisms that may provide a causal link between visceral fat and metabolic consequences of obesity. On the other hand, there is also good evidence for causal associations between many of the potentially confounding factors and metabolic disturbances. It seems likely, however, that there is not a single culprit but rather a concerted action of a large series of interacting factors which may be the orchestral version of the`deadly quartet'. 
